ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In an ...
Hosted on MSN
Bio-Techne Corporation (TECH): A Bull Case Theory
We came across a bullish thesis on Bio-Techne Corporation on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on TECH. Bio-Techne Corporation's share was ...
Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, pharmaceutical, diagnostics and bioprocessing markets worldwide. In 2013, Bio-Techne ...
Bio-Techne faces near-term growth headwinds from challenges in academic and biotech research funding, but retains strong leverage to growing spatial biology, proteomics, and cell/gene therapy research ...
Fintel reports that on November 20, 2025, Argus Research maintained coverage of Bio-Techne (NasdaqGS:TECH) with a Buy recommendation. As of November 17, 2025, the average one-year price target for Bio ...
Scientists from Covenant University, Ota, Ogun State yesterday, validated the potent anti-microbial and energy-boosting properties of structured water generated using QNET’s innovative Amezcua Bio ...
The Graduate Architecture, Urban Design, and Landscape Architecture programs (GA/LA/UD) at Pratt Institute are proud to participate in the Biodesign Challenge (BDC) with their project submission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results